OpenAlex
PricingAboutJobs
Log inGet started
Work

Evaluating TBK1 as a Therapeutic Target in Cancers with Activated IRF3

HTML

Year: 2014
Type: article
Source: Molecular Cancer Research
DOI: 10.1158/1541-7786.mcr-13-0642
Authors: Asli Muvaffak, Qi Pan, Haiyan Yan, Rafael Fernandez, Jongwon Lim, Brian Dolinski, Thi T. Nguyen, Peter Strack, Stephen Wu, Rossana Chung, Weiqun Zhang, Chris Hulton, Steven Ripley, Heather Hirsch, Kumiko Nagashima, Kwok-Kin Wong, Pasi A. Jánne, Cynthia Seidel-Dugan, Leigh Zawel, Paul T. Kirschmeier, Richard E. Middleton, Erick J. Morris, Yan Wang
Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Dana-Farber Cancer Institute
Language: English

Topic: NF-κB Signaling Pathways
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2124179567
FWCI: 0.778
Cites: 36
Cited by: 49
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms